Viking Global Investors LP, a hedge fund run by Andreas Halvorsen, filed a 13G today disclosing a new position in MDVN. Viking Global Investors owned 1,954,749 shares or a 5.3% stake in the company as of August 8th, 2012.
From Yahoo! Finance, Medivation, Inc., a biopharmaceutical company, focuses on developing novel small molecule drugs for the treatment of serious diseases in the United States and Europe.
|Reported via||Date||Name||Ticker||Shares||% of Portfolio|
|SC 13G||2012-08-08||Medivation, Inc.||MDVN||1,954,749||N/A|